» Articles » PMID: 17426130

Comparison of Approaches for Rational SiRNA Design Leading to a New Efficient and Transparent Method

Overview
Specialty Biochemistry
Date 2007 Apr 12
PMID 17426130
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Current literature describes several methods for the design of efficient siRNAs with 19 perfectly matched base pairs and 2 nt overhangs. Using four independent databases totaling 3336 experimentally verified siRNAs, we compared how well several of these methods predict siRNA cleavage efficiency. According to receiver operating characteristics (ROC) and correlation analyses, the best programs were BioPredsi, ThermoComposition and DSIR. We also studied individual parameters that significantly and consistently correlated with siRNA efficacy in different databases. As a result of this work we developed a new method which utilizes linear regression fitting with local duplex stability, nucleotide position-dependent preferences and total G/C content of siRNA duplexes as input parameters. The new method's discrimination ability of efficient and inefficient siRNAs is comparable with that of the best methods identified, but its parameters are more obviously related to the mechanisms of siRNA action in comparison with BioPredsi. This permits insight to the underlying physical features and relative importance of the parameters. The new method of predicting siRNA efficiency is faster than that of ThermoComposition because it does not employ time-consuming RNA secondary structure calculations and has much less parameters than DSIR. It is available as a web tool called 'siRNA scales'.

Citing Articles

Development, Design, and Application of Efficient siRNAs Against Cotton Leaf Curl Virus-Betasatellite Complex to Mediate Resistance Against Cotton Leaf Curl Disease.

Jain H, Kaur R, Sain S, Siwach P Indian J Microbiol. 2024; 64(2):558-571.

PMID: 39011016 PMC: 11246389. DOI: 10.1007/s12088-024-01191-z.


ASOptimizer: Optimizing antisense oligonucleotides through deep learning for IDO1 gene regulation.

Hwang G, Kwon M, Seo D, Kim D, Lee D, Lee K Mol Ther Nucleic Acids. 2024; 35(2):102186.

PMID: 38706632 PMC: 11066473. DOI: 10.1016/j.omtn.2024.102186.


RNAi-based drug design: considerations and future directions.

Tang Q, Khvorova A Nat Rev Drug Discov. 2024; 23(5):341-364.

PMID: 38570694 PMC: 11144061. DOI: 10.1038/s41573-024-00912-9.


Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer.

de Miguel F, Gentile C, Feng W, Silva S, Sankar A, Exposito F Cancer Cell. 2023; 41(8):1516-1534.e9.

PMID: 37541244 PMC: 10957226. DOI: 10.1016/j.ccell.2023.07.005.


Chemistry, structure and function of approved oligonucleotide therapeutics.

Egli M, Manoharan M Nucleic Acids Res. 2023; 51(6):2529-2573.

PMID: 36881759 PMC: 10085713. DOI: 10.1093/nar/gkad067.


References
1.
Mathews D, Burkard M, Freier S, Wyatt J, Turner D . Predicting oligonucleotide affinity to nucleic acid targets. RNA. 1999; 5(11):1458-69. PMC: 1369867. DOI: 10.1017/s1355838299991148. View

2.
Yiu S, Wong P, Lam T, Mui Y, Kung H, Lin M . Filtering of ineffective siRNAs and improved siRNA design tool. Bioinformatics. 2004; 21(2):144-51. DOI: 10.1093/bioinformatics/bth498. View

3.
Vickers T, Koo S, Bennett C, Crooke S, Dean N, Baker B . Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem. 2002; 278(9):7108-18. DOI: 10.1074/jbc.M210326200. View

4.
Schwarz D, Hutvagner G, Du T, Xu Z, Aronin N, Zamore P . Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003; 115(2):199-208. DOI: 10.1016/s0092-8674(03)00759-1. View

5.
Santoyo J, Vaquerizas J, Dopazo J . Highly specific and accurate selection of siRNAs for high-throughput functional assays. Bioinformatics. 2004; 21(8):1376-82. DOI: 10.1093/bioinformatics/bti196. View